Our Contributors BioTech Health X Latest from BioTech Health X Alterome Therapeutics Strengthens Leadership Team with Appointment of Renowned Oncologist Dr. Andrew S. Chi as Chief Medical Officer 11/19/21 Welcome To BioTech Health X Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022 Jak Thomson Studied UC Davis School of Medicine. Enjoy Surfing, Sunning and Helping People. Bylines and analysis in Biotech on major publications. Current Biotech Analyst & Consultant. Latest from Jak Thomson Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future BenchSci Expands Advisory Board with New Pharma R&D Leaders MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV) Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma Presenters Announced for 2021 William Blair Biotech Conference
